Jones D - Search Results

1

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma.

Pagliaro L, Daliani D, Amato R, Tu SM, Jones D, Smith T, Logothetis C, Millikan R. Pagliaro L, et al. Among authors: jones d. Cancer. 2000 Aug 1;89(3):615-8. Cancer. 2000. PMID: 10931461 Clinical Trial.

2

Phase II study of didemnin B in advanced colorectal cancer.

Jones DV Jr, Ajani JA, Blackburn R, Daugherty K, Levin B, Patt YZ, Abbruzzese JL. Jones DV Jr, et al. Invest New Drugs. 1992 Aug;10(3):211-3. doi: 10.1007/BF00877248. Invest New Drugs. 1992. PMID: 1428730 Clinical Trial.

3

Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma.

Pazdur R, Bready B, Ajani JA, Abbruzzese JL, Markowitz A, Sugarman S, Jones D, Levin B. Pazdur R, et al. Among authors: jones d. Am J Clin Oncol. 1995 Oct;18(5):436-8. doi: 10.1097/00000421-199510000-00015. Am J Clin Oncol. 1995. PMID: 7572763 Clinical Trial.

4

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV Jr, Markowitz AB, Abbruzzese JL, Bready B, et al. Pazdur R, et al. Among authors: jones dv jr. J Clin Oncol. 1994 Nov;12(11):2296-300. doi: 10.1200/JCO.1994.12.11.2296. J Clin Oncol. 1994. PMID: 7964943 Clinical Trial.

5

A phase II study of merbarone in patients with adenocarcinoma of the pancreas.

Jones DV Jr, Ajani JA, Winn RJ, Daugherty KR, Levin B, Krakoff IH. Jones DV Jr, et al. Cancer Invest. 1993;11(6):667-9. doi: 10.3109/07357909309046939. Cancer Invest. 1993. PMID: 8221199 Clinical Trial.

6

A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver.

Jones DV Jr, Patt YZ, Ajani JA, Abbruzzese J, Carrasco CH, Charnsangavej C, Levin B, Wallace S. Jones DV Jr, et al. Cancer. 1993 Nov 1;72(9):2560-3. doi: 10.1002/1097-0142(19931101)72:9<2560::aid-cncr2820720908>3.0.co;2-e. Cancer. 1993. PMID: 8402476 Clinical Trial.

7

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Kurzrock R, et al. Among authors: jones d. Cancer Res. 1993 May 1;53(9):2118-22. Cancer Res. 1993. PMID: 8481913

8

Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma.

Moore DF Jr, Pazdur R, Sugarman S, Jones D 3rd, Lippman SM, Bready B, Abbruzzese JL. Moore DF Jr, et al. Among authors: jones d 3rd. Am J Clin Oncol. 1995 Dec;18(6):525-7. doi: 10.1097/00000421-199512000-00013. Am J Clin Oncol. 1995. PMID: 8526197 Clinical Trial.

9

Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.

Jones DV Jr, Winn RJ, Brown BW, Levy LB, Pugh RP, Wade JL 3rd, Gross HM, Pendergrass KB, Levin B, Abbruzzese JL. Jones DV Jr, et al. Cancer. 1995 Nov 15;76(10):1709-14. doi: 10.1002/1097-0142(19951115)76:10<1709::aid-cncr2820761006>3.0.co;2-5. Cancer. 1995. PMID: 8625038 Clinical Trial.

10

Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.

Patt YZ, Jones DV Jr, Hoque A, Lozano R, Markowitz A, Raijman I, Lynch P, Charnsangavej C. Patt YZ, et al. Among authors: jones dv jr. J Clin Oncol. 1996 Aug;14(8):2311-5. doi: 10.1200/JCO.1996.14.8.2311. J Clin Oncol. 1996. PMID: 8708722 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,459 results

Search Page

Filters